Terazosin

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

Synonyms / Brand Names: Terazosin HCl, Terazosin hydrochloride, Terazosina, Terazosine, Terazosinum, Trazosin HCl, Abbott 45975, Blavin, Flumarc, Fosfomic, Heitrin, Hytracin, Hytrin, Hytrinex, Itrin, Urodie, Vasocard, Vasomet, Vicard

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Dosing and Administration

Benign prostatic hyperplasia

  • Initial dose: 1 mg at bedtime is the starting dose for all patients, and this dose should not be exceeded as an initial dose. Patients should be closely followed during initial administration in order to minimize the risk of severe hypotensive response.

Hypertension

  • Initial dose: 1 mg at bedtime is the starting dose for all patients, and this dose should not be exceeded. This initial dosing regimen should be strictly observed to minimize the potential for severe hypotensive effects.




FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Terazosin

Return to top

Publication Resources

Most Recent Articles on Terazosin

Review Articles on Terazosin

Articles on Terazosin in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Terazosin

Return to top

Trial Resources

Ongoing Trials with Terazosin at Clinical Trials.gov

Trial Results with Terazosin

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Terazosin

Cochrane Collaboration on Terazosin

Cost Effectiveness of Terazosin

Return to top

Media Resources

Powerpoint Slides on Terazosin

Images of Terazosin

Podcasts & MP3s on Terazosin

Videos on Terazosin

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Terazosin

Discussion Groups on Terazosin

Patient Handouts on Terazosin

Blogs on Terazosin

Terazosin in the News

Terazosin in the Marketplace

Return to top

International Resources

Terazosin en Español

Return to top


The content of this page is taken from the FDA package insert for this drug and should not be edited.

Personal tools